Whalegun
List

Truth Social post of August 11, 2026

PostRegulation tightenedPublished 08/11Open the original

Summary

President Trump said that, at his direction, Dr. Mehmet Oz announced Medicaid will no longer fund gender transition surgeries and hormones for minors, adding that dozens of hospitals have already ended such care.

By industry

Day by day after the announcement

Healthcare & Drug Pricing stocks and the S&P 500 after the announcement, cumulative %
Healthcare & Drug Pricing stocks and the S&P 500 after the announcement, cumulative %
DayHealthcare & Drug Pricing stocksS&P 500
26/08/100.0%0.0%
26/08/11−0.3%−0.3%
26/08/12−0.5%−0.0%
26/08/13−0.4%+0.7%
26/08/14−0.2%+0.4%
26/08/17−0.6%−0.0%
26/08/18+0.9%−0.7%
26/08/19+2.9%−0.3%
26/08/20+1.2%−1.2%
26/08/21+2.5%−0.9%
26/08/24+3.1%−1.1%
26/08/25+3.9%−0.9%
26/08/26+3.4%−0.3%
26/08/27+2.1%−0.3%
26/08/28+1.7%−0.5%
26/08/31+1.6%−0.7%
26/09/01+3.5%−1.4%
26/09/02+4.4%−1.0%
26/09/03+4.9%−0.0%
26/09/04+3.6%−0.4%
26/09/08+1.1%−0.9%

Korean stocks in these industries

  • Samsung Biologics 207940
  • Celltrion 068270
  • SK Biopharmaceuticals 326030

Trades in these industries around the announcement

Members' and insiders' trades in the industries' stocks, 30 days before to 30 days after.

  • Kevin Hern

    Full saleUnitedhealth Group

    $15K–$50K

    Reported 09/25

  • Sheldon Whitehouse

    Partial saleAmgen

    $1K–$15K

    Reported 09/02

  • Thomas H. Kean Jr.

    Partial saleJohnson & Johnson

    $1K–$15K

    Reported 09/12

  • John Boozman

    Partial saleJohnson & Johnson

    $1K–$15K

    Reported 09/11

  • David Taylor

    Full saleAmgen

    $1K–$15K

    Reported 09/05

  • David Taylor

    Full saleAmgen

    $1K–$15K

    Reported 09/05

  • Maria Salazar

    BuyMerck

    $15K–$50K

    Reported 09/09

  • Maria Salazar

    BuyMerck

    $15K–$50K

    Reported 09/09